NovaLead Pharma to conduct Phase 3 trial for its repurposed anti COVID-19 drug EP News Bureau May 14, 2020 In a comparable viral assay study conducted by reputed laboratories in South Korea and United States, the drug, NLP21 has shown…
CSIR identifies top 25 drugs/drug candidates for repurposing Press Information Bureau May 1, 2020 Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs
AI can play a big role in vaccine development for COVID-19 Raelene Kambli Apr 30, 2020 Deepak Jha, Deputy General Manager- AIPF (Artificial Intelligence Platform), NEC Technologies India elaborates on the role AI can…
Computational methodologies can be effective in predicting and prioritising key targets related to… Lakshmipriya Nair Apr 13, 2020 Supreet Deshpande, CEO, NovaLead Pharma shares more insights on how computational technologies can revolutionise pharma R&D…